Vital signs monitoring devices measure the basic functions in humans including pulse rate, body temperature, respiration rate, and blood pressure.
Vital Signs Monitoring Devices Market Overview:
Vital signs monitoring devices measure the basic functions in humans including pulse rate, body temperature, respiration rate, and blood pressure. These devices are used in a medical setting, home, and at the site of a medical emergency as they offer to provide critical information regarding a patient’s health to detect acute medical problems, such as chronic diseases state.
According to Allied Market Research, the global vital signs monitoring devices market is expected to reach $7.81 billion by 2026, growing at a CAGR of 6.6% from 2019 to 2026. Rise in the geriatric population, the surge in demand for portable monitoring devices, and technological advancements drive the market growth.
Over the last few years, Wearable Health Devices (WHDs) are rapidly being used to help people better check their health both for self-health tracking and tracking fitness. Moreover, these devices are extremely vital offer vital data to clinicians with potential for early diagnostic and offering guidance of treatment. This trend has entered vital signs monitoring devices to improve health care. Moreover, people have become more cognizant and aware of the benefits of maintaining a healthy lifestyle. Owing to the Covid-19 outbreak, the demand for vital signs monitoring devices has increased and investment from major market players to launch new, more accurate devices has surged significantly.
Recently, BioIntelliSense, a clinical intelligence company, announced to launch new device to improve the standard of remote patient care and launched BioButton, a medical-grade rechargeable wearable device. The device offers multi-parameter monitoring of more than 20 vital signs as well as physiologic biometrics for around 30 days on a single charge. Moreover, the set of indicators enables early identification and identification of adverse trends to enhance patient monitoring safety.
Prior to this, VitalConnect, Inc., a leading company in wearable biosensor technology, launched its VitalPatch RTM cardiac monitoring solutions for patients and for those who demand extended Holter monitoring. The new device can monitor around 21 cardiac arrhythmias through its AI-based ECG analysis solution and captures data of vital signs, offering a holistic view of the patient’s health condition.
Such devices have offered new hope for those who need continuous monitoring and need support. Owing to the surge in importance of vital signs monitoring devices in developed countries and the increase in the global geriatric population have boosted the demand for vital signs monitoring devices. Over the new few years, technologies in vital signs monitoring devices would improve and the awareness regarding these devices would surge.
Request for Sample Report for More Insights @ https://www.alliedmarketresearch.com/request-sample/527
Top Leading Players:
- Hill-Rom Holdings, Inc.
- Halma plc (SunTech Medical, Inc.)
- Nonin Medical, Inc.
- Omron Corporation
- Masimo Corporation
- General Electric Company
- Medtronic plc
- Nihon Kohden Corporation
- Koninklijke Philips N.V.
- A&D Company
- Limited Contec Medical System
- Smiths Group plc.
Covid-19 scenario-
The outbreak of the Covid-19 pandemic has had a positive impact on the vital signs monitoring devices market, since fetal bovine serum has widely been utilized in the making of vaccines as well as in the preparation of in-vitro cell-culture. This serum is used as an add-on in the growth media for the vaccines, which in turn has been highly beneficial for the market. This trend is most likely to continue till the pandemic is completely over.